EX-99.1 2 tm2420298d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Amended Loan Schedule to Secured Promissory Note dated November 10, 2022

between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC 

 

   Date   Principal  Aggregated Principal
           
  Original Secured Promissory Note   11/10/2022   $2,319,279  $2,319,279
  Additional loans to be included:           
               Loan #1   12/22/2022   $250,000  $2,569,279
               Loan #2   1/19/2023   $250,000  $2,819,279
               Loan #3   2/22/2023   $250,000  $3,069,279
               Loan #4   3/20/2023   $250,000  $3,319,279
               Loan #5   5/19/2023   $150,000  $3,469,279
               Loan #6   7/10/2023   $200,000  $3,669,279
               Loan #7   7/28/2023   $250,000  $3,919,279
               Loan #8   8/30/2023   $250,000  $4,169,279
               Loan #9   10/11/2023   $250,000  $4,419,279
               Loan #10   12/04/2023   $250,000  $4,669,279
               Loan #11   1/08/2024   $250,000  $4,919,279
               Loan #12   2/14/2024   $250,000  $5,169,279
               Loan #13   3/14/2024   $250,000  $5,419,279
               Loan #14   5/10/2024   $200,000  $5,619,279
               Loan #15   6/03/2024   $75,000  $5,694,279
               Loan #16   6/14/2024   $200,000  $5,894,279
               Loan #17   7/03/2024   $150,000  $6,044,279
               Loan #18   7/22/2024   $100,000  $6,144,279

  

ACURA PHARMACEUTICALS, INC.

 

By: /s/ Robert A. Seiser

Robert A. Seiser

Vice President & Treasurer

Date: July 22, 2024